Pfizer's four business units may be combined into two, a top company official said, triggering speculation by analysts that the world's biggest drugmaker is preparing to split in half.
Pfizer's possible unit shuffle triggers breakup concern
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You